Symposium:
34. Update on Finding and Treating Patients with Hepatitis B
Thursday, October 8, 2015: 10:30 AM-12:00 PM
Room: 6--DE
Co-organized with the National Institute of Allergy and Infectious Diseases

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe strategies to identify persons with chronic hepatitis B infection in the United States
  • recognize criteria for the treatment of hepatitis B infection in immunocompetent patients
  • distinguish treatment goals for chronic hepatitis B infection in immunocompromised patients
  • describe novel drugs in development for the eradication of hepatitis B

Target Audience: Vaccinologists, Scientists, Public health practitioners, Pharmacists, Nurses, Members-in-training, Infectious diseases physicians, HIV specialists, HIV clinicians, Healthcare workers, Fellows, Epidemiologists, Clinicians, Academicians

Tracks: HIV-STD-TB, Global ID, Adult ID, Trainee

Moderators:  Chloe Thio, MD, FIDSA, Johns Hopkins University School of Medicine and Paul Griffiths, MD, DSc, University College London

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-15-153-L01-P

Disclosures:

C. Thio, None

P. Griffiths, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.